Breaking News Instant updates and real-time market news.

2020-05-28 07:14:05 MRNA Moderna $52.19 / -5.54 (-9.60%) 07:14 05/28/20 05/28 07:14 05/28/20 07:14	Moderna study of COVID-19 vaccine now recruiting, clinicaltrials.gov site shows A post, dated May 28, to the website clinicaltrials.gov indicates that Moderna's clinical study to assess the safety, reactogenicity, and immunogenicity of 2 dose levels of mRNA-1273 SARS-COV-2 vaccine in adults 18 years of age or older is now recruiting. Reference Link	29 May 02 Jun
MRNA Moderna $52.19 / -5.54 (-9.60%) 05/26/20 Maxim ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim 05/20/20 Morgan Stanley Moderna price target raised to $90 from $37 at Morgan Stanley 05/19/20 Piper Sandler Piper trims Moderna target to $100 on capital raise dilution 05/19/20 BMO Capital Moderna price target raised to $112 from $83 at BMO Capital

2020-05-28 07:14:05

MRNA

Moderna

$52.19 / -5.54 (-9.60%)

07:14

05/28/20

05/28

07:14

05/28/20

07:14

Moderna study of COVID-19 vaccine now recruiting, clinicaltrials.gov site shows

A post, dated May 28, to the website clinicaltrials.gov indicates that Moderna's clinical study to assess the safety, reactogenicity, and immunogenicity of 2 dose levels of mRNA-1273 SARS-COV-2 vaccine in adults 18 years of age or older is now recruiting. Reference Link

29
May
02
Jun

MRNA Moderna

$52.19 / -5.54 (-9.60%)

05/26/20 Maxim: ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim

05/20/20 Morgan Stanley: Moderna price target raised to $90 from $37 at Morgan Stanley

05/19/20 Piper Sandler: Piper trims Moderna target to $100 on capital raise dilution

05/19/20 BMO Capital: Moderna price target raised to $112 from $83 at BMO Capital

TODAY'S FREE FLY STORIES

Syndicate	Phio Pharmaceuticals announces $14M private placement priced at-the-market » 15:35 01/21/21 01/21 15:35 01/21/21 15:35 PHIO Phio Pharmaceuticals $3.07 / + (+0.00%) Phio Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PHIO Phio Pharmaceuticals $3.07 / + (+0.00%) 08/05/20 Fly Intel: Top five analyst initiations 08/05/20 H.C. Wainwright Phio Pharmaceuticals initiated with a Buy at H.C. Wainwright
Periodicals	Judge sides with Amazon in Parler web-hosting case, NPR says » 15:34 01/21/21 01/21 15:34 01/21/21 15:34 AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) U.S. District Judge… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 01/19/21 Amazon invests in five new facilities in Quebec, creates over 1,000 new jobs 01/15/21 FCA announced as first OEM to implement Amazon's new Alexa Custom Assistant 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Lion Electric CEO: We are not an overnight success AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 08:39 Today BofA Amazon.com price target raised to $4,000 from $3,650 at BofA 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/11/21 Baird Baird remains a buyer of Amazon ahead of Q4 results 12/22/20 Wells Fargo Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 01/14/21 Fly Intel: What to watch in first round of big bank earnings reports 10/29/20 Amazon.com sees Q4 revenue $112B-$121B, consensus $112.32B 10/29/20 Amazon.com reports Q3 EPS $12.37, consensus $7.41 07/30/20 Amazon.com sees Q3 sales $87B-$93B, consensus $86.29B AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 15:04 Today Parler loses request for injunction against Amazon, Bloomberg reports 01/20/21 Amazon's Twitch 'indefinitely' suspends Donald Trump, Verge says 01/20/21 Amazon says 'ready to assist' with COVID vaccination efforts, GeekWire reports 01/20/21 Amazon sues EU regulators for allowing Italian case to proceed, Reuters says AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 02/02/21 Amazon.com - AMZN AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 12/31/20 Unusually active option classes on open December 31st 12/29/20 Unusually active option classes on open December 29th 10/26/20 Early notable gainers among liquid option names on October 26th 08/18/20 Early notable gainers among liquid option names on August 18th
Options	Seagate options imply 7.9% move in share price post-earnings » 15:34 01/21/21 01/21 15:34 01/21/21 15:34 STX Seagate $62.26 / +0.83 (+1.35%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options STX Seagate $62.26 / +0.83 (+1.35%) 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products 11/05/20 Climb Channel Solutions adds Seagate data storage systems to distribution line STX Seagate $62.26 / +0.83 (+1.35%) 07:08 Today Barclays Seagate price target raised to $60 from $41 at Barclays 01/20/21 Wedbush Seagate price target raised to $56 from $47 at Wedbush 01/19/21 Northland Seagate price target raised to $72 from $65 at Northland 01/19/21 Loop Capital Seagate price target raised to $70 from $60 at Loop Capital STX Seagate $62.26 / +0.83 (+1.35%) 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c 10/22/20 Notable companies reporting after market close 10/22/20 Fly Intel: What to watch in data storage earnings reports STX Seagate $62.26 / +0.83 (+1.35%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/23/20 Fly Intel: Pre-market Movers 16:30 Today Seagate - STX STX Seagate $62.26 / +0.83 (+1.35%) 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish 10/22/20 Seagate put volume heavy and directionally bearish
Options	Ambarella call volume above normal and directionally bullish » 15:25 01/21/21 01/21 15:25 01/21/21 15:25 AMBA Ambarella $110.03 / +4.97 (+4.73%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AMBA Ambarella $110.03 / +4.97 (+4.73%) 01/11/21 Ambarella unveils CV5 AI vision processor with 8K capabilities 12/28/20 FAA adopts final rules for drones 'advancing opportunities' for utilization 12/02/20 AWS partnering with Nvidia and Ambarella to enable AWS Panorama Device SDK 12/01/20 Ambarella CTO sells 20K shares of common stock AMBA Ambarella $110.03 / +4.97 (+4.73%) 07:47 Today Stifel Ambarella price target raised to $118 from $110 at Stifel 01/13/21 Roth Capital Ambarella upgraded to Buy with $130 price target at Roth Capital 01/13/21 Roth Capital Ambarella upgraded to Buy from Neutral at Roth Capital 01/05/21 Craig-Hallum Ambarella price target raised to $115 from $90 at Craig-Hallum AMBA Ambarella $110.03 / +4.97 (+4.73%) 11/24/20 Ambarella sees Q4 revenue $56M-$60M, consensus $52.31M 11/23/20 Ambarella reports Q3 EPS 9c, consensus 5c 09/02/20 Ambarella sees Q3 revenue $52M-$56M, consensus $55.12M 09/02/20 Ambarella reports Q2 EPS 6c, consensus (2c) AMBA Ambarella $110.03 / +4.97 (+4.73%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 12/07/20 Fly Insider: Foot Locker, Alexion among weeks notable insider trades 11/23/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference AMBA Ambarella $110.03 / +4.97 (+4.73%) 12/10/20 Ambarella call volume above normal and directionally bullish 12/03/20 Ambarella call volume above normal and directionally bullish 11/23/20 Ambarella options imply 12.9% move in share price post-earnings 09/01/20 Ambarella call volume above normal and directionally bullish
Conference/Events	Jefferies auto/auto parts analyst to hold an analyst/industry conference call » 15:25 01/21/21 01/21 15:25 01/21/21 15:25 Auto & Auto Parts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Periodicals	Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports » 15:21 01/21/21 01/21 15:21 01/21/21 15:21 PFE Pfizer $36.45 / -0.035 (-0.10%) , BNTX BioNTech $107.01 / +3.71 (+3.59%) Pfizer (PFE) has cut in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 07:09 Today Cerevel Therapeutics appoints Deval Patrick, Deborah Baron to board 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus 01/14/21 Pfizer says FDA approves supplemental NDA for Xalkori 01/14/21 Oragenics issues letter to stockholders on Terra CoV-2 BNTX BioNTech $107.01 / +3.71 (+3.59%) 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus 01/12/21 Canada orders 20M more doses of Pfizer, BioNTech Covid vaccine 01/08/21 Pfizer, BioNTech COVID vaccine elicits antibodies that neutralize mutation 01/07/21 BioNTech reports publication of preclinical data on novel mRNA vaccine approach PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg BNTX BioNTech $107.01 / +3.71 (+3.59%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 12/15/20 Jefferies Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play' PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 BNTX BioNTech $107.01 / +3.71 (+3.59%) 08/11/20 BioNTech reports Q2 EPS (EUR38c), consensus (EUR24c) 07/31/20 Pfizer, BioNTech to supply Japan with 120M doses of BNT162 vaccine candidate 23 Jul 06 Feb PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 14:52 Today Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says 01/20/21 Japan inks deal with Pfizer for COVID vaccine for 72M people, Nikkei reports 01/20/21 Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports BNTX BioNTech $107.01 / +3.71 (+3.59%) 14:52 Today Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says 01/20/21 Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports 01/04/21 Pfizer, BioNTech offered South Africa discounted vaccines, Bloomberg says PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $107.01 / +3.71 (+3.59%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/02/21 2021 London Global Healthcare Virtual Conference 02/02/21 Pfizer - PFE 01/24/21 PDUFA Date for Xalkori (Crizotinib) - January 2021 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th 12/11/20 Notable open interest changes for December 11th BNTX BioNTech $107.01 / +3.71 (+3.59%) 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names 11/20/20 Unusually active option classes on open November 20th 11/02/20 Largest borrow rate increases among liquid names
Periodicals	Biden poised to freeze oil, coal leasing on federal land, Bloomberg says » 15:20 01/21/21 01/21 15:20 01/21/21 15:20 ACI Albertsons $17.43 / +0.12 (+0.69%) , ANR Alpha Natural $0.00 / + (+0.00%) , ARLP Alliance Resource Partners $5.26 / -0.25 (-4.54%) , CNX CNX Resources $12.32 / -0.13 (-1.04%) , BTU Peabody Energy $3.48 / -0.495 (-12.47%) , CLDP Cloud Peak Energy $0.00 / + (+0.00%) President Joe Biden is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ACI ANR ARLP CNX BTU ACI Albertsons $17.43 / +0.12 (+0.69%) 11/30/20 Albertsons associates ratify agreement with UFCW local unions 11/24/20 Albertsons implements contactless temperature, health screening 11/19/20 Albertsons incorporates SNAP EBT payments at Drive Up & Go locations 11/12/20 Albertsons to partner with HHS to provide COVID-19 vaccine ANR Alpha Natural $0.00 / + (+0.00%) 07/27/20 Deutsche Bank seeks to exit global business activities in coal mining by 2025 ARLP Alliance Resource Partners $5.26 / -0.25 (-4.54%) 07/27/20 Deutsche Bank seeks to exit global business activities in coal mining by 2025 CNX CNX Resources $12.32 / -0.13 (-1.04%) 11/16/20 Einhorn's Greenlight buys Twitter, exits Whirlpool in Q3 10/22/20 CNX Resources rises after Bloomberg reports on EQT takeover interest 10/22/20 CNX Resources jumps 16% to $11.99 after Bloomberg report of EQT bid 09/28/20 CNX Resources, CNX Midstream Partners announce completion of merger BTU Peabody Energy $3.48 / -0.495 (-12.47%) 12:00 Today Peabody Energy falls -11.8% 10:00 Today Peabody Energy falls -7.9% 01/06/21 Peabody Energy falls -6.6% 01/05/21 Peabody Energy rises 13.8% ACI ANR ARLP CNX BTU CLDP ACI Albertsons $17.43 / +0.12 (+0.69%) 01/20/21 Morgan Stanley Albertsons downgraded to Underweight with $13 price target at Morgan Stanley 01/20/21 Morgan Stanley Kroger downgraded to Underweight at Morgan Stanley 01/20/21 Morgan Stanley Albertsons downgraded to Underweight from Equal Weight at Morgan Stanley 01/15/21 Tigress Financial Tigress continues to recommend Albertsons purchases, sees further upside ANR Alpha Natural $0.00 / + (+0.00%) ARLP Alliance Resource Partners $5.26 / -0.25 (-4.54%) 02/04/20 Benchmark Benchmark starts 'under-owned and shunned' Alliance Resource Partners at Buy 02/04/20 Benchmark Alliance Resource Partners initiated with a Buy at Benchmark CNX CNX Resources $12.32 / -0.13 (-1.04%) 01/15/21 JPMorgan CNX Resources initiated with an Overweight at JPMorgan 12/15/20 BofA CNX Resources initiated with a Neutral at BofA 12/15/20 BofA CNX Resources initiated with a Neutral at BofA 10/30/20 MKM Partners CNX Resources upgraded to Buy from Neutral at MKM Partners BTU Peabody Energy $3.48 / -0.495 (-12.47%) 08/07/20 Vertical Research Peabody Energy downgraded to Hold from Buy at Vertical Research 05/07/20 Clarksons Platou Peabody Energy downgraded to Neutral from Buy at Clarksons Platou 03/20/20 Deutsche Bank Peabody Energy downgraded to Hold from Buy at Deutsche Bank 02/10/20 Benchmark Benchmark starts Arch Coal at Buy, sees opportunity after selloff CLDP Cloud Peak Energy $0.00 / + (+0.00%) ACI CNX BTU ACI Albertsons $17.43 / +0.12 (+0.69%) 01/12/21 Albertsons raises FY20 adjusted EPS view to $3.05-$3.15 from $2.75-$2.85 01/12/21 Albertsons reports Q3 adjusted EPS 66c, consensus 42c 01/11/21 Notable companies reporting before tomorrow's open 01/11/21 Notable companies reporting before tomorrow's open CNX CNX Resources $12.32 / -0.13 (-1.04%) 07/30/20 CNX Resources reports Q2 EPS (78c), consensus 2c BTU Peabody Energy $3.48 / -0.495 (-12.47%) 11/09/20 Peabody Energy reports Q3 cont ops EPS 66c, consensus 92c 08/05/20 Peabody Energy reports Q2 EPS ($15.76), consensus ($1.28) 26 Jun ACI CNX ACI Albertsons $17.43 / +0.12 (+0.69%) 09/19/20 Albertsons a Buy as stock looks cheap, Barron's says CNX CNX Resources $12.32 / -0.13 (-1.04%) 10/22/20 EQT pursuing acquisition of CNX Resources, Bloomberg reports 10/22/20 EQT recently made takeover proposal to CNX Resources, Bloomberg says 10/22/20 EQT said to pursue acquisition of CNX Resources, Bloomberg reports ACI CNX ACI Albertsons $17.43 / +0.12 (+0.69%) 01/12/21 Fly Intel: Pre-market Movers 11/09/20 Fly Intel: What to watch in Beyond Meat earnings report 10/20/20 Fly Intel: Pre-market Movers 10/14/20 Fly Intel: After-Hours Movers CNX CNX Resources $12.32 / -0.13 (-1.04%) 10/23/20 Fly Intel: Pre-market Movers 10/22/20 Fly Intel: Wall Street's top stories for Thursday 07/27/20 Fly Intel: Wall Street's top stories for July 27 07/27/20 Fly Intel: Wall Street's top stories at midday 01/28/21 CNX Resources - CNX 02/01/21 Alliance Resource Partners - ARLP ACI BTU ACI Albertsons $17.43 / +0.12 (+0.69%) 01/13/21 Largest borrow rate increases among liquid names 01/12/21 Largest borrow rate increases among liquid names 01/11/21 Largest borrow rate increases among liquid names 01/07/21 Largest borrow rate increases among liquid names BTU Peabody Energy $3.48 / -0.495 (-12.47%) 12/29/20 Unusual call flow in option market yesterday 08/11/20 Largest borrow rate increases among liquid names
Options	CSX options imply 4.6% move in share price post-earnings » 15:19 01/21/21 01/21 15:19 01/21/21 15:19 CSX CSX $91.77 / -1.45 (-1.56%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CSX CSX $91.77 / -1.45 (-1.56%) 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 12/31/20 North American rail traffic rose 7% in week ended December 26 CSX CSX $91.77 / -1.45 (-1.56%) 01/20/21 Susquehanna Railroad recovery expected to continue in 2021, says Susquehanna 01/11/21 Citi CSX price target raised to $105 from $87 at Citi 12/10/20 Morgan Stanley Morgan Stanley downgrades CSX to Underweight with bar raised too high 12/10/20 Morgan Stanley CSX downgraded to Underweight from Equal Weight at Morgan Stanley CSX CSX $91.77 / -1.45 (-1.56%) 14:41 Today Notable companies reporting after market close 10/21/20 CSX reports Q3 EPS 96c, consensus 92c 10/21/20 Notable companies reporting after market close 07/22/20 CSX reports Q2 EPS 65c, consensus 64c CSX CSX $91.77 / -1.45 (-1.56%) 10/21/20 Fly Intel: After-Hours Movers 16:30 Today CSX - CSX CSX CSX $91.77 / -1.45 (-1.56%) 10/22/20 Early notable gainers among liquid option names on October 22nd 09/15/20 CSX call volume above normal and directionally bullish 09/04/20 CSX put volume heavy and directionally bearish 07/31/20 CSX call volume above normal and directionally bullish
Technical Analysis	NASDAQ market internals summary » 15:17 01/21/21 01/21 15:17 01/21/21 15:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 15:16 01/21/21 01/21 15:16 01/21/21 15:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary

Hot Stocks	Momentus announces service agreement with Qosmosys » 15:14 01/21/21 01/21 15:14 01/21/21 15:14 SRAC Stable Road Acquisition $23.70 / -0.56 (-2.31%) Momentus and Qosmosys… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals Options SRAC Stable Road Acquisition $23.70 / -0.56 (-2.31%) 01/04/21 Momentus to delay its January launch further into 2021 10/07/20 Momentus to become public through merger with Stable Road Acquisition SRAC Stable Road Acquisition $23.70 / -0.56 (-2.31%) 10/06/20 Stable Road in talks to bring Momentus public via merger, Bloomberg says 10/06/20 Momentus in talks to go public via Stable Road Acquisition deal, Bloomberg says SRAC Stable Road Acquisition $23.70 / -0.56 (-2.31%) 01/04/21 Largest borrow rate increases among liquid names 12/31/20 Largest borrow rate increases among liquid names 12/16/20 Stable Road Acquisition Corporation put volume heavy and directionally bearish 12/02/20 Largest borrow rate increases among liquid names
Recommendations	Unibail-Rodamco-Westfield price target lowered to EUR 45 at Barclays » 15:13 01/21/21 01/21 15:13 01/21/21 15:13 UNBLF Unibail-Rodamco-Westfield $0.00 / + (+0.00%) Barclays analyst Sander… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research UNBLF Unibail-Rodamco-Westfield $0.00 / + (+0.00%) 12/10/20 Goldman Sachs Unibail-Rodamco-Westfield upgraded to Buy from Neutral at Goldman Sachs 12/07/20 Deutsche Bank Unibail-Rodamco-Westfield price target lowered to EUR 70 at Deutsche Bank 11/24/20 Goldman Sachs Unibail-Rodamco-Westfield upgraded to Neutral from Sell at Goldman Sachs 11/23/20 JPMorgan Unibail-Rodamco-Westfield resumed with an Underweight at JPMorgan
Recommendations	Svenska Handelsbanken price target raised to SEK 105 from SEK 102 at Barclays » 15:11 01/21/21 01/21 15:11 01/21/21 15:11 SVNLY Svenska Handelsbanken $0.00 / + (+0.00%) Barclays analyst Namita… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SVNLY Svenska Handelsbanken $0.00 / + (+0.00%) 01/14/21 SEB Equities Svenska Handelsbanken upgraded to Hold from Sell at SEB Equities 01/11/21 UBS Svenska Handelsbanken price target raised to SEK 89 from SEK 82 at UBS 12/09/20 Deutsche Bank Svenska Handelsbanken price target raised to SEK 112 at Deutsche Bank 12/01/20 JPMorgan Svenska Handelsbanken price target lowered to SEK 70 from SEK 75 at JPMorgan
Recommendations	Smith & Nephew price target lowered to 1,875 GBp from 1,900 GBp at Barclays » 15:10 01/21/21 01/21 15:10 01/21/21 15:10 SNN Smith & Nephew $44.83 / -1.04 (-2.27%) Barclays analyst Hassan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SNN Smith & Nephew $44.83 / -1.04 (-2.27%) 01/04/21 Integra LifeSciences completes sale of Extremity Orthopedics unit to Smith & Nephew 11/20/20 Smith & Nephew notes that FY20 guidance remains withdrawn 09/29/20 Integra to divest Extremity Orthopedics business to Smith & Nephew for $240M SNN Smith & Nephew $44.83 / -1.04 (-2.27%) 13:47 Today Berenberg Smith & Nephew price target raised to 2,005 GBp from 1,975 GBp at Berenberg 01/20/21 Berenberg Smith & Nephew price target raised to 2,005 GBp from 1,975 GBp at Berenberg 12/18/20 JPMorgan Smith & Nephew price target lowered to 1,438 GBp from 1,596 GBp at JPMorgan 12/18/20 Bernstein Smith & Nephew upgraded to Outperform from Market Perform at Bernstein
Recommendations	Pearson price target raised to 630 GBp from 520 GBp at Barclays » 15:10 01/21/21 01/21 15:10 01/21/21 15:10 PSO Pearson $9.81 / -0.23 (-2.29%) Barclays analyst Nick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PSO Pearson $9.81 / -0.23 (-2.29%) 12/02/20 Pearson announces Mike Howells as new Chief Strategy Officer 10/14/20 Pearson 'on track' to deliver 2020 outturn in line with expectations 08/24/20 Pearson names Disney executive Andy Bird as new CEO, effective October 19 PSO Pearson $9.81 / -0.23 (-2.29%) 05:14 Today Exane BNP Paribas Pearson downgraded to Neutral from Outperform at Exane BNP Paribas 01/12/21 Berenberg Pearson price target raised to 475 GBp from 450 GBp at Berenberg 12/17/20 UBS Pearson price target raised to 750 GBp from 650 GBp at UBS 12/09/20 Fly Intel: Top five analyst downgrades PSO Pearson $9.81 / -0.23 (-2.29%) 10/14/20 Pearson reports Q3 revenue down 10% y/y vs. down 28% in Q2 07/24/20 Pearson reports 1H EPS 6.3p versus 6.1p in 1H19

Recommendations	Nordea Bank price target raised to SEK 7.60 from SEK 7.40 at Barclays » 15:09 01/21/21 01/21 15:09 01/21/21 15:09 NRDBY Nordea Bank $0.00 / + (+0.00%) Barclays analyst Namita… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals Events NRDBY Nordea Bank $0.00 / + (+0.00%) 12/09/20 Deutsche Bank Nordea Bank upgraded to Buy from Hold at Deutsche Bank 12/01/20 JPMorgan Nordea Bank price target raised to SEK 75 from SEK 70 at JPMorgan 11/30/20 Barclays Nordea Bank price target raised to EUR 7.40 from EUR 7.30 at Barclays 11/20/20 JPMorgan Nordea Bank price target raised to SEK 70 from SEK 65 at JPMorgan NRDBY Nordea Bank $0.00 / + (+0.00%) 08/31/20 Activists caution Samsung C&T over Vietnam coal project, Bloomberg reports 02/04/21 Nordea Bank - NRDBY
Hot Stocks	Old Point Financial announces Q4 pre-tax expenses of $1M » 15:06 01/21/21 01/21 15:06 01/21/21 15:06 OPOF Old Point Financial $20.75 / +0.75 (+3.75%) Old Point Financial plans… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	IMI PLC price target raised to 1,465 GBp from 1,230 GBp at Barclays » 15:06 01/21/21 01/21 15:06 01/21/21 15:06 IMIAY IMI PLC $0.00 / + (+0.00%) Barclays analyst Jonathan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research IMIAY IMI PLC $0.00 / + (+0.00%) 01/18/21 Goldman Sachs IMI PLC upgraded to Conviction Buy from Buy at Goldman Sachs 01/15/21 Morgan Stanley IMI PLC price target raised to 1,400 GBp from 1,320 GBp at Morgan Stanley 01/13/21 Credit Suisse IMI PLC upgraded to Outperform at Credit Suisse on guidance upside 01/13/21 Credit Suisse IMI PLC upgraded to Outperform from Neutral at Credit Suisse
Periodicals	Parler loses request for injunction against Amazon, Bloomberg reports » 15:04 01/21/21 01/21 15:04 01/21/21 15:04 AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) Previously it was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 01/19/21 Amazon invests in five new facilities in Quebec, creates over 1,000 new jobs 01/15/21 FCA announced as first OEM to implement Amazon's new Alexa Custom Assistant 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Lion Electric CEO: We are not an overnight success AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 08:39 Today BofA Amazon.com price target raised to $4,000 from $3,650 at BofA 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/11/21 Baird Baird remains a buyer of Amazon ahead of Q4 results 12/22/20 Wells Fargo Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 01/14/21 Fly Intel: What to watch in first round of big bank earnings reports 10/29/20 Amazon.com sees Q4 revenue $112B-$121B, consensus $112.32B 10/29/20 Amazon.com reports Q3 EPS $12.37, consensus $7.41 07/30/20 Amazon.com sees Q3 sales $87B-$93B, consensus $86.29B AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 01/20/21 Amazon's Twitch 'indefinitely' suspends Donald Trump, Verge says 01/20/21 Amazon says 'ready to assist' with COVID vaccination efforts, GeekWire reports 01/20/21 Amazon sues EU regulators for allowing Italian case to proceed, Reuters says 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 02/02/21 Amazon.com - AMZN AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 12/31/20 Unusually active option classes on open December 31st 12/29/20 Unusually active option classes on open December 29th 10/26/20 Early notable gainers among liquid option names on October 26th 08/18/20 Early notable gainers among liquid option names on August 18th
Options	IBM options imply 6.3% move in share price post-earnings » 15:04 01/21/21 01/21 15:04 01/21/21 15:04 IBM IBM $132.01 / +1.93 (+1.48%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IBM IBM $132.01 / +1.93 (+1.48%) 01/19/21 IBM, Atos expand strategic global alliance for digital transformation 01/14/21 IBM to acquire Taos, terms not disclosed 01/14/21 Vonage names Jay Bellissimo as COO 01/11/21 IBM acquires 7Summits, terms not disclosed IBM IBM $132.01 / +1.93 (+1.48%) 10/20/20 Morgan Stanley Morgan Stanley continues to view IBM as 'a 2022 stock' 10/20/20 Citi IBM is 'getting even more complex,' says Citi 10/20/20 BMO Capital IBM price target lowered to $138 from $140 at BMO Capital 10/09/20 Morgan Stanley IBM price target raised to $140 from $128 at Morgan Stanley IBM IBM $132.01 / +1.93 (+1.48%) 14:41 Today Notable companies reporting after market close 10/19/20 IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7% 10/19/20 IBM reports Q3 adjusted EPS $2.58, consensus $2.58 10/19/20 Notable companies reporting after market close IBM IBM $132.01 / +1.93 (+1.48%) 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/06/21 IBM restructuring sales organization, WSJ reports 11/25/20 IBM to eliminate 10,000 positions in Europe ahead of unit sale, Bloomberg says 10/11/20 IBM split might not mean speedy recovery, WSJ says IBM IBM $132.01 / +1.93 (+1.48%) 12:29 Today Fly Intel: What to watch in IBM's earnings report 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 17:00 Today IBM - IBM IBM IBM $132.01 / +1.93 (+1.48%) 01/05/21 Unusually active option classes on open January 5th 10/30/20 IBM call volume above normal and directionally bullish 10/19/20 IBM options imply 6.1% move in share price post-earnings 10/08/20 Early notable gainers among liquid option names on October 8th

Recommendations	DNB ASA price target raised to NOK 131 from NOK 120 at Barclays » 15:03 01/21/21 01/21 15:03 01/21/21 15:03 DNHBY DNB ASA $0.00 / + (+0.00%) Barclays analyst Namita… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DNHBY DNB ASA $0.00 / + (+0.00%) 01/11/21 Berenberg DNB ASA price target raised to NOK 180 from NOK 150 at Berenberg 01/11/21 UBS DNB ASA downgraded to Sell from Neutral at UBS 12/09/20 Deutsche Bank DNB ASA price target raised to NOK 180 from NOK 151 at Deutsche Bank 12/01/20 JPMorgan DNB ASA price target raised to NOK 180 from NOK 165 at JPMorgan
Recommendations	Danske Bank price target raised to DKK 105 from DKK 104 at Barclays » 15:02 01/21/21 01/21 15:02 01/21/21 15:02 DNKEY Danske Bank $0.00 / + (+0.00%) Barclays analyst Namita… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DNKEY Danske Bank $0.00 / + (+0.00%) 01/11/21 UBS Danske Bank price target raised to DKK 138 from DKK 130 at UBS 12/09/20 Deutsche Bank Danske Bank price target raised to DKK 115 from DKK 104 at Deutsche Bank 12/01/20 JPMorgan Danske Bank price target lowered to DKK 95 from DKK 98 at JPMorgan 11/24/20 Morgan Stanley Danske Bank downgraded to Underweight from Equal Weight at Morgan Stanley
Recommendations	BASF price target raised to EUR 64 from EUR 60 at Barclays » 15:01 01/21/21 01/21 15:01 01/21/21 15:01 BASFY BASF $0.00 / + (+0.00%) Barclays analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals Events BASFY BASF $0.00 / + (+0.00%) 13:32 Today Deutsche Bank BASF price target raised to EUR 86 from EUR 71 at Deutsche Bank 01/15/21 Berenberg BASF price target raised to EUR 74 from EUR 52 at Berenberg 01/12/21 Bernstein BASF upgraded to Outperform from Market Perform at Bernstein 01/11/21 JPMorgan BASF downgraded to Underweight from Neutral at JPMorgan BASFY BASF $0.00 / + (+0.00%) 07/29/20 Bayer sends PI to U.S. farm in bid to overturn weedkiller decision, Reuters says 02/26/21 BASF - BASFY
Periodicals	CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says » 15:01 01/21/21 01/21 15:01 01/21/21 15:01 CSGP CoStar Group $902.59 / +1.59 (+0.18%) , CLGX CoreLogic $77.33 / +1.625 (+2.15%) CoStar Group (CSGP) and a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 12/29/20 Apartments.com Network acheives 1B website visits in 2020 12/18/20 CoStar Group acquires Houses.com 12/17/20 CoStar Group receives FTC clearance to close acquisition of Homesnap 11/30/20 FTC sues to block CoStar Group's proposed acquisition of RentPath CLGX CoreLogic $77.33 / +1.625 (+2.15%) 12/11/20 CoreLogic expects final bids for company in early 2021 11/24/20 CoreLogic board 'fully supportive' of 'robust' sale process 11/23/20 Cannae, Senator ask CoreLogic to set board vote record date 11/17/20 CoreLogic shareholders elect Senator, Cannae nominees to board CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 12/22/20 JMP Securities RealPage price target raised to $101 from $80 at JMP Securities 11/23/20 Wells Fargo CoStar Group price target raised to $990 from $915 at Wells Fargo 10/28/20 Truist CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist 10/28/20 Needham CoStar Group price target raised to $1,000 from $825 at Needham CLGX CoreLogic $77.33 / +1.625 (+2.15%) 01/06/21 Wolfe Research CoreLogic downgraded to Underperform from Peer Perform at Wolfe Research 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist 10/28/20 Truist CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 10/27/20 CoStar Group sees FY20 EPS $9.39-$9.49, consensus $9.36 10/27/20 CoStar Group sees Q4 EPS $2.34-$2.44, consensus $2.51 10/27/20 CoStar Group reports Q3 EPS $2.26, consensus $2.07 07/28/20 CoStar Group sees FY20 adjusted EPS $9.22-$9.42, consensus $9.11 CLGX CoreLogic $77.33 / +1.625 (+2.15%) 12/11/20 CoreLogic raises FY21 adjusted EPS view to $4.40-$4.65 from $4.00-$4.20 12/11/20 CoreLogic raises FY20 adjusted EPS view to $4.15-$4.25 from $3.65 10/22/20 CoreLogic sees FY20 results at upper end of guidance range 10/22/20 CoreLogic reports Q3 EPS $1.21, consensus $1.24 21 May CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 14:43 Today CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says 12/29/20 Rentpath terminates deal to be acquired by CoStar Group, Bloomberg says 11/22/20 CoStar in advanced talks to acquire Homesnap for $250M, WSJ reports 10/28/20 CoreLogic receiving buyout interest above $80 per share, CNBC reports CLGX CoreLogic $77.33 / +1.625 (+2.15%) 14:43 Today CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says 12/01/20 CoreLogic interest seen being 'strong,' CTFN reports 12/01/20 CTFN publishes report on CoreLogic auction plans 11/17/20 CoreLogic investors likely to win three board seats, Bloomberg reports CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 10/28/20 Fly Intel: Wall Street's top stories for Wednesday 10/28/20 Fly Intel: Wall Street's top stories at midday CLGX CoreLogic $77.33 / +1.625 (+2.15%) 10/28/20 Fly Intel: Wall Street's top stories for Wednesday 10/28/20 Fly Intel: Wall Street's top stories at midday
Recommendations	Aveva price target raised to 3,730 GBp from 3,560 GBp at Barclays » 15:00 01/21/21 01/21 15:00 01/21/21 15:00 AVEVF Aveva $0.00 / + (+0.00%) Barclays analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events AVEVF Aveva $0.00 / + (+0.00%) 08/25/20 Aveva to acquire OSIsoft for $5B AVEVF Aveva $0.00 / + (+0.00%) 01/20/21 Berenberg Aveva upgraded to Buy from Hold at Berenberg 01/05/21 UBS Aveva upgraded to Buy from Neutral at UBS 01/04/21 Investec Aveva upgraded to Buy from Hold at Investec 12/11/20 Credit Suisse Aveva price target lowered to 3,620 GBp from 4,690 GBp at Credit Suisse 02/11/21 Technology & Internet Virtual Conference

Events

Earnings calls, analyst events, roadshows and more

Today at 16:00

Autos & Auto Parts Industry Meetings
KRBP
Today at 16:15

Kiromic BioPharma - KRBP Conference Calls
CSX
Today at 16:30

CSX - CSX Conference Calls
STX
Today at 16:30

Seagate - STX Conference Calls
IDXG
Today at 16:30

Interpace Biosciences - IDXG Conference Calls
TENX
Today at 16:30

Tenax Therapeutics - TENX Conference Calls
ISRG
Today at 16:30

Intuitive Surgical - ISRG Conference Calls
FOR
Today at 17:00

Forestar Group - FOR Conference Calls
PBCT
Today at 17:00

People's United - PBCT Conference Calls
ASB
Today at 17:00

Associated Banc-Corp - ASB Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Moderna study of COVID-19 vaccine now recruiting, clinicaltrials.gov site shows

TODAY'S FREE FLY STORIES

Get Full Fly Access